ARTICLE | Company News
Epigenomics, Roche deal
August 16, 2004 7:00 AM UTC
ECX received an undisclosed milestone from ROCZ under a 2003 deal to develop molecular diagnostic and pharmacogenomic cancer products based on ECX's DNA-methylation technologies (see BioCentury March ...